BALEZENTIS CARL W

Director at LARK TECHNOLOGIES INC · on record since Apr 29, 2004
President at LARK TECHNOLOGIES INC · on record since Apr 29, 2004
Pres., Enzo Life Sciences at ENZO BIOCHEM INC · on record since Feb 2, 2010
Sr. V.P & President, Lark at GENAISSANCE PHARMACEUTICALS INC · on record since Jan 21, 2005

Insider trading activity of BALEZENTIS CARL W

Transactions on record: 20; since Apr 29, 2004

Open-market buys: 0

Open-market sells: 4; $71.5K

Companies traded: 3; last filing Dec 20, 2010

Figures computed from official regulatory filings — .

Companies where BALEZENTIS CARL W has traded

ENZO BIOCHEM INC7 tx · $71.5K · Dec 20, 2010
GENAISSANCE PHARMACEUTICALS INC8 tx · $481K · Jan 21, 2005
LARK TECHNOLOGIES INC5 tx · Apr 29, 2004

Track record of BALEZENTIS CARL W

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BALEZENTIS CARL W

Co-insiders of BALEZENTIS CARL W

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ENZO BIOCHEM INCListing unverified	Dec 20, 2010	Sell	-12,724	5.12 USD	$65.1K	Unusual size	SEC
ENZO BIOCHEM INCListing unverified	Jul 2, 2010	Sell	-30	6.23 USD	$186.9		SEC
ENZO BIOCHEM INCListing unverified	Feb 2, 2010	Award	12,000	—	n/a (No price was disclosed in the filing)		SEC
ENZO BIOCHEM INCListing unverified	Jan 26, 2009	Award	10,000	—	n/a (No price was disclosed in the filing)		SEC
ENZO BIOCHEM INCListing unverified	Nov 4, 2008	Sell	-580	5.35	$3.1K		SEC
ENZO BIOCHEM INCListing unverified	Nov 3, 2008	Sell	-580	5.35	$3.1K		SEC
ENZO BIOCHEM INCListing unverified	Dec 11, 2007	Award	7,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Jan 21, 2005	AwardD (derivative)	60,000	2.20 USD	$132K		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Jan 21, 2005	Award	20,000	0.00 USD	$20		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	58,186	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	31,675	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	100,000	3.49 USD	$349K		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	32,147	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	63,350	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	31,675	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	60,000	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	35,000	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	108,600	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ENZO BIOCHEM INCListing unverified	Dec 20, 2010	Sell	-12,724	5.12 USD	$65.1K	Unusual size	SEC
ENZO BIOCHEM INCListing unverified	Jul 2, 2010	Sell	-30	6.23 USD	$186.9		SEC
ENZO BIOCHEM INCListing unverified	Feb 2, 2010	Award	12,000	—	n/a (No price was disclosed in the filing)		SEC
ENZO BIOCHEM INCListing unverified	Jan 26, 2009	Award	10,000	—	n/a (No price was disclosed in the filing)		SEC
ENZO BIOCHEM INCListing unverified	Nov 4, 2008	Sell	-580	5.35	$3.1K		SEC
ENZO BIOCHEM INCListing unverified	Nov 3, 2008	Sell	-580	5.35	$3.1K		SEC
ENZO BIOCHEM INCListing unverified	Dec 11, 2007	Award	7,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Jan 21, 2005	AwardD (derivative)	60,000	2.20 USD	$132K		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Jan 21, 2005	Award	20,000	0.00 USD	$20		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	58,186	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	31,675	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	100,000	3.49 USD	$349K		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	32,147	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	63,350	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	31,675	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	60,000	—	n/a (No price was disclosed in the filing)		SEC
LARK TECHNOLOGIES INCListing unverified	Apr 29, 2004	OtherD (derivative)	35,000	—	n/a (No price was disclosed in the filing)		SEC
GENAISSANCE PHARMACEUTICALS INCListing unverified	Apr 29, 2004	AwardD (derivative)	108,600	—	n/a (No price was disclosed in the filing)		SEC